Community post
Saima Aslam and colleagues at University of California, San Diego have announced Phase I/II phage vs placebo trial for recurrent E. coli UTIs in female kidney transplant recipients.
Topics
| Source | Capsid & Tail #322 |
|---|
Saima Aslam and colleagues at University of California, San Diego have announced Phase I/II phage vs placebo trial for recurrent E. coli UTIs in female kidney transplant recipients.
| Source | Capsid & Tail #322 |
|---|